IP Library Granted Patent US 11,254,941
Granted Patent B2
US 11,254,941 · App. 16/642,792 · Granted Feb 22, 2022

RNA nanostructures and methods of making and using RNA nanostructures

Inventors: Hao Yan (Chandler, AZ); Yung Chang (Tempe, AZ); Xiaowei Liu (Tempe, AZ); Fei Zhang (Chandler, AZ); Xiaodong Qi (Tempe, AZ)
Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
C12N15/117B82Y5/00C12N2310/51
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,254,941
App. No.
16/642,792
Granted
Feb 22, 2022
Kind
B2
Abstract

Certain embodiments provide RNA nanostructure (e.g., comprising one single-stranded RNA (ssRNA) molecule, wherein the RNA nanostructure comprises at least one paranemic cohesion crossover), as well as compositions and methods of use thereof. In certain embodiments, such RNA nanostructures are immuno-modulatory (e.g., immuno-stimulatory).

Claims (11)

1. An RNA nanostructure comprising at least one single-stranded RNA (ssRNA) molecule,

wherein the RNA nanostructure comprises at least two structural repeating units of 33 nucleotides in length, and wherein each structural repeating unit comprises, in order: a first region of a double helix 8 nucleotides in length, a first paranemic cohesion crossover 8 nucleotides in length, a second region of a double helix 9 nucleotides in length, and a second paranemic cohesion crossover 8 nucleotides in length.

2. An RNA nanostructure comprising a nucleic acid sequence having at least about 75% sequence identity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12 or SEQ ID NO:13.

3. The RNA nanostructure of claim 2 , wherein the nucleic acid sequence has at least about 85% sequence identity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10 or SEQ ID NO:11, SEQ ID NO:12 or SEQ ID NO:13.

4. The RNA nanostructure of claim 2 , wherein the nucleic acid sequence has at least about 95% sequence identity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10 or SEQ ID NO:11, SEQ ID NO:12 or SEQ ID NO:13.

5. The RNA nanostructure of claim 2 wherein the nucleic acid sequence has at least about 99% sequence identity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10 or SEQ ID NO:11, SEQ ID NO:12 or SEQ ID NO:13.

6. The RNA nanostructure of claim 2 , comprising SEQ ID NO:1.

7. The RNA nanostructure of claim 2 , consisting of SEQ ID NO:1.

8. The RNA nanostructure of any one of claims 1 - 7 , wherein the RNA nanostructure has rectangular, diamond, triangle, or tetrahedron shape.

9. A nucleic acid having at least about 75% identity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12 or SEQ ID NO:13.

10. The nucleic acid of claim 9 , wherein the nucleic acid has at least about 90% identity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12 or SEQ ID NO:13.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2020
From: YAN, HAO; CHANG, YUNG; LIU, XIAOWEI; ZHANG, FEI; QI, XIAODONG
To: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
Reel/Frame 052842/0961 →
Continuity (8)
Provisional Application 62637807 · Mar 2, 2018
Provisional Application 62630020 · Feb 13, 2018
Provisional Application 62625965 · Feb 2, 2018
Provisional Application 62596697 · Dec 8, 2017
Provisional Application 62594473 · Dec 4, 2017
Provisional Application 62594471 · Dec 4, 2017
Provisional Application 62552183 · Aug 30, 2017
Related Publication 20210246452A1 · Aug 12, 2021
Cited By (1)
US 12,473,553